Growing Fears

Your good article on the "rising tide of irrationalism" [F. Hoke, "Scientists See Broad Attack Against Research And Reason," The Scientist, July 10, 1995, page 1] starts appropriately with a picture captioned "GROWING FEARS" and ends with a mainstream scientist's plaintive cry: "We are the oppressed. We have to find a voice." In between, we read about "the vitriolic tone of many of the speakers . . . polarizing vehemence . . . extreme and virulent form, almost hate- mongering. . . ." This is no

Written byTheodore Rockwell
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Robert L. DuPont, former president of the Phobia Institute, studied similar rhetoric many years ago and called it clinically phobic -- not a rational fear of a present danger, but an hysterical reaction to an hypothesized possibility. DuPont was referring to the response of the media and much of the public to nuclear power. He took no position as to the desirability of nuclear power; he just said that the response was phobic, not rational.

Scientists can discuss some outrageous ideas, such as intergalactic strings and electrons running backward in time, and these discussions remain rational. But it's easy to see when buttons have been pushed and rationality has been shoved aside. This is such a case.

Paul Kurtz refers in the article to the fact that a trivial fraction of the National Institutes of Health budget is being devoted, for the first time, to studying some medical approaches long ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies